Sjögren's syndrome: Diagnosis and treatment;Diagnóstico e tratamento da síndrome de Sjögren

Arquivos Brasileiros de Oftalmologia

Volumn 69, Issue 6, 2006, Pages 959-963

  Felberg, Sergio ^a,c   Correa Dantas, Paulo Elias ^b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c R Conselheiro Brotero   (Brazil)

Author keywords

Dry eye syndromes; Keratoconjunctivitis sicca; Sj gren's syndrome diagnosis; Sj gren's syndrome therapy; Xerophthalmia; Xerostomia

Indexed keywords

EID: 33846804577     PISSN: 00042749     EISSN: 16782925     Source Type: Journal    
DOI: 10.1590/s0004-27492006000600032     Document Type: Article

References (37)

1. Rehman HU. Sjogren's syndrome. Yonsei Med J. 2003;44(6):947-54. Review.
2. Moutsopoulos HM, Chused TM, Mann DL, Klippel JH, Fauci AS, Frank MM, et al. Sjogren's syndrome (Sicca syndrome): current issues. Ann Intern Med. 1980;92(2 Pt 1):212-26.
3. Jonsson R, Moen K, Vestrheim D, Szodoray P. Current issues in Sjogren's syndrome. Oral Dis. 2002;8(3):130-40. Review.
4. Asmussen KH, Bowman SJ. Outcome measures in Sjogren's syndrome. Rheumatology (Oxford). 2001;40(10):1085-8. Review.
5. Asmussen K, Andersen V, Bendixen G, Benditzen K, Prause JU, Thorn J, et al. Quantitative assessment of clinical disease status in primary Sjogren's syndrome. A cross-sectional study using a new classification model. Scand J Rheumatol. 1997;26(3):197-205.
6. Aragona P, Magazzu G, Macchia G, Bartolone S, Di Pasquale G, Vitali C, Ferreri G. Presence of antibodies against Helicobacter pylori and its heat-shock protein 60 in the serum of patients with Sjogren's syndrome. J Rheumatol. 1999;26(6):1306-11.
7. Abe T, Nakajima A, Matsunaga M, Sakuragi S, Komatsu M. Decreased tear lactoferrin concentration in patients with chronic hepatitis C. Br J Ophthalmol. 1999;83(6):684-7.
8. Hayashi Y, Arakaki R, Ishimaru N. Apoptosis and estrogen deficiency in primary Sjogren syndrome. Curr Opin Rheumatol. 2004;16(5):522-6.
9. Hansen A, Lipsky PE, Dorner T. New concepts in the pathogenesis of Sjogren syndrome: many questions, fewer answers. Curr Opin Rheumatol. 2003; 15(5):563-70.
10. Yamamoto K. Pathogenesis of Sjogren's syndrome. Autoimmun Rev. 2003;2 (1):13-8.
11. Esch TR. Pathogenetic factors in Sjogren's syndrome: recent developments. Crit Rev Oral Biol Med. 2001;12(3):244-51.
12. Bowman SJ, Pillemer S, Jonsson R, Asmussen K, Vitali C, Manthorpe R, Sutcliffe N. Contributors to and participants at the workshop. Revisiting Sjogren's syndrome in the new millenium: perspectives on assessment and outcome measures. Report of a workshop held on 23 March 2000 at Oxford, UK. Rheumatalogy (Oxford). 2001;40(10):1180-8.
13. Rozman B, Novljan MP, Hocevar A, Ambrozic A, Zigon P, Kveder T, Tomsic M. Epidemiology and diagnostics of primary Sjogren's syndrome. Reumatizam. 2004;51(2):9-12. Review.
14. Hay EM, Thomas E, Pal B, Hajeer A, Chambers H, Silman AJ. Weak association between subjective symptoms or and objective testing for dry eyes and dry mouth: results from a population based study. Ann Rheum Dis. 1998;57(1):20-4.
15. Kassan SS, Moutsopoulos HM. Clinical manifestations and early diagnosis of Sjogren syndrome. Arch Intern Med. 2004;164(12):1275-84.
16. Kalk WW, Mansour K, Vissink A, Spijkervet FK, Bootsma H, Kallenberg CG, et al. Oral and ocular manifestations in Sjogren's syndrome. J Rheumatol. 2002;29(5):924-30.
17. Nishiwaki-Dantas MC. Olho seco. Arq Bras Oftalmol. 2000;62(1):101-5.
18. Nichols KK, Nichols JJ, Lynn Mitchell G. The relation between tear film tests in patients with dry eye disease. Ophthalmic Physiol Opt. 2003;23(6):553-60.
19. Toda I. Autoantigens and Sjogren syndrome. Cornea. 2002;21(2 Suppl 1): S13-6. Review.
20. Harley JB, Alexander EL, Bias WB, Fox OF, Provost TT, Reichlin M, et al. Anti-Ro (SS-A) and anti-La (SS-B) in patients with Sjogren's syndrome. Arthritis Rheum. 1986;29(2):196-206.
21. Daniels TE, Whitcher JP. Association of patterns of labial salivary gland inflammation with keratoconjunctivitis sicca. Analysis of 618 patients with suspected Sjogren's syndrome. Arthritis Rheum. 1994;37(6):869-77.
22. Fox RI, Robinson CA, Curd JG, Kozin F, Howell FV. Sjogren's syndrome. Proposed criteria for classification. Arthritis Rheum. 1986;29(5):577-85.
23. Vitali C, Bonbardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Kassan SS, Pillemer SR, Talal N, Weisman MH; European Study Group on Classification Criteria for Sjögren's Syndrome. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61(6):554-8. Review.
24. Fox RI, Michelson P. Approaches to the treatment of Sjogren's syndrome. J Rheumatol Suppl. 2000;61:15-21. Review.
25. Aragona P, Di Stefano G, Ferreri F, Spinella R, Stilo A. Sodium hyaluronate eye drops of different osmolarity for the treatment of dry eye in Sjogren's syndrome patients. Br J Ophthalmol. 2002;86(8):879-84.
26. Noble BA, Loh RS, MacLennan S, Pesudovs K, Reynolds A, Bridges LR, et al. Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease. Br J Ophthalmol. 2004;88(5):647-52.
27. Derk CT, Vivino FB. A primary care approach to Sjogren's syndrome. Helping patients cope with sicca symptoms, extraglandular manifestations. Postgrad Med. 2004;116(3):49-54,59,65.
28. Ono M, Takamura E, Shinozaki K, Tsumura T, Hamano T, Yagi Y, Tsubota K. Therapeutic effect of cevimeline on dry eye in patients with Sjogren's syndrome: a randomized, double-blind clinical study. Am J Ophthalmol. 2004;138(1):6-17.
29. Nelson JD, Friedlaender M, Yeatts RP, Yee R, McDermott M, Orlin S, et al. Oral pilocarpine for symptomatic relief of keratoconjunctivitis sicca in patients with Sjogren's syndrome. The MGI PHARMA Sjogren's Syndrome Study Group. Adv Exp Med Biol. 1998;438:979-83.
30. Petrone D, Condemi JJ, Fife R, Gluck'O, Cohen S, Dalgin P. A double-blind, randomized, placebo-controlled study of cevimeline in Sjogren's syndrome patients with xerostomia and keratoconjunctivitis sicca. Arthritis Rheum. 2002;46(3):748-54.
31. Avunduk AM, Avunduk MC, Varnell ED, Kaufman HE. The comparison of efficacies of topical corticosteroids and nonsteroidal anti-inflammatory drops on dry eye patients: a clinical and immunocytochemical study. Am J Ophthalmol. 2003;136(4):593-602.
32. Gunduz K, Ozdemir O. Topical cyclosporin treatment of keratoconjunctivitis sicca in secondary Sjogren's syndrome. Acta Ophthalmol (Copenh). 1994;72 (4):438-42.
33. Sullivan DA, Sullivan BD, Evans JE, Schirra F, Yamagami H, Liu M, et al. Androgen deficiency, Meibomian gland dysfunction, and evaporative dry eye. Ann N Y Acad Sci. 2002;966:211-22.
34. Brown NA, Bron AJ, Harding JJ, Dewar HM. Nutrition supplements and the eye. Eye. 1998;12(Pt 1):127-33.
35. Ferraccioli GF, Salaffi F, De Vita S, Casatta L, Avellini C, Carotti M, et al. Interferon alpha-2 (IFN alpha 2) increases lacrimal and salivary function in Sjogren's syndrome patients. Preliminary results of an open pilot trial versus OH-chloroquine. Clin Exp Rheumatol. 1996;14(4):367-71.
36. Sheppard JD. Guidelines for the treatment of chronic dry eye disease. Manag Care. 2003;12(12 Suppl):20-5.
37. Fox RI. Sjogren's syndrome: current therapies remain inadequate for a common disease. Expert Opin Investig Drugs. 2000;9(9):2007-16.